A Phase I/IIa trial of AZD4547 in combination with Cisplatin and Capecitabine (CX)
Phase of Trial: Phase I/II
Latest Information Update: 11 Dec 2015
At a glance
- Drugs AZD 4547 (Primary) ; Capecitabine; Cisplatin
- Indications Gastric cancer; Oesophageal cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Acronyms FACING
- 24 Nov 2015 Status changed from completed to discontinued as reported by ISRCTN: Current Controlled Trials Record.
- 05 Mar 2015 Status changed from recruiting to completed, as reported by United Kingdom Clinical Research Network record.
- 18 Jul 2014 Accrual to date is 20% according to United Kingdom Clinical Research Network record.